What is Zoe?
Zoe operates within the health and wellness sector, focusing on a holistic approach to understanding and improving human biology. The company leverages advanced diagnostic tests and cutting-edge scientific research to provide users with comprehensive insights into their gut microbiome, blood sugar responses, and blood fat reactions. By identifying and helping to reduce dietary inflammation, Zoe aims to empower individuals to enhance their gut health naturally through personalized biological data.
How much funding has Zoe raised?
Zoe has raised a total of $15M across 1 funding round:
Series B
$15M
Series B (2024): $15M with participation from Coefficient Capital
Key Investors in Zoe
Coefficient Capital
Coefficient Capital is an investment firm that focuses on transformational consumer shifts, particularly the intersection of the physical and digital worlds. They aim to connect innovative consumer trends with investment opportunities, supporting founders in navigating evolving markets.
What's next for Zoe?
The recent major enterprise-level funding and strategic investment in Zoe's Series B round signal a strong market validation and provide substantial resources for scaling operations. This capital infusion is likely to fuel further research and development, expansion of testing capabilities, and broader market penetration. Zoe is positioned to further solidify its leadership in personalized gut health and inflammation management, potentially exploring new diagnostic avenues and enhancing its digital health platform to deliver more integrated wellness solutions.
See full Zoe company page
